SANUWAVE Health, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
SANUWAVE Health, Inc. (SNWV) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-08-06
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $43.00K, a 186.67% increase year-over-year.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $36.00K, a 60.87% decline year-over-year.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-06-30 was $5.00K.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-03-31 was $0.00.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $84.00K, a 68.06% decline from fiscal 2024.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $263.00K, a 56.17% decline from fiscal 2023.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $600.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $27.00K 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $79.00K derived: sum of 2 quarters · filed 2026-03-26 | $84.00K derived: sum of 3 quarters · filed 2026-08-06 | $84.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $41.00K derived: sum of 2 quarters · filed 2026-08-06 | $41.00K 10-Q · filed 2025-11-06 | $56.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.00K 10-Q · filed 2026-08-06 | $20.00K derived: sum of 3 quarters · filed 2026-08-06 | $112.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $15.00K derived: sum of 2 quarters · filed 2026-03-26 | $107.00K derived: sum of 3 quarters · filed 2026-03-26 | ||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $107.00K derived: sum of 2 quarters · filed 2026-03-26 | $263.00K 10-K · filed 2026-03-26 | $400.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $248.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $156.00K 10-Q · filed 2025-08-07 | ||||
| 2023-12-31 | $600.00K 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |